FWA
RDY icon

FSC Wealth Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

FSC Wealth Advisors’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,020
Closed -$40.4K – 290
2023
Q3 		$40.4K Buy
+3,020
New +$40.9K 0.04% 84

Other funds holding RDY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

FSC Wealth Advisors's RDY Position: Q4 2023 in Review

FSC Wealth Advisors sold out of Dr. Reddy's Laboratories (RDY) in Q4 2023, closing a stake of 3,020 shares — an estimated $40.4K sold.

FSC Wealth Advisors first reported a position in RDY in Q3 2023 and held it in 1 quarter. The position peaked at $40.4K in Q3 2023. 224 funds tracked by Wall St. Rank hold RDY as of Q4 2023.

  • FSC Wealth Advisors reported no remaining Dr. Reddy's Laboratories position as of Q4 2023 after selling out during the quarter.
  • FSC Wealth Advisors sold 3,020 Dr. Reddy's Laboratories shares in Q4 2023, an estimated $40.4K.
  • FSC Wealth Advisors first reported a position in Dr. Reddy's Laboratories in Q3 2023 and held it in 1 quarter.
  • FSC Wealth Advisors's Dr. Reddy's Laboratories position peaked at $40.4K in Q3 2023.
  • 224 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2023.

Based on FSC Wealth Advisors's 13F filing for Q4 2023, filed 16 Jan 2024.